Selected article for: "cell activation and inflammatory response"

Author: Manley, Grace C. A.; Parker, Lisa C.; Zhang, Yongliang
Title: Emerging Regulatory Roles of Dual-Specificity Phosphatases in Inflammatory Airway Disease
  • Cord-id: v0bks8g8
  • Document date: 2019_2_5
  • ID: v0bks8g8
    Snippet: Inflammatory airway disease, such as asthma and chronic obstructive pulmonary disease (COPD), is a major health burden worldwide. These diseases cause large numbers of deaths each year due to airway obstruction, which is exacerbated by respiratory viral infection. The inflammatory response in the airway is mediated in part through the MAPK pathways: p38, JNK and ERK. These pathways also have roles in interferon production, viral replication, mucus production, and T cell responses, all of which a
    Document: Inflammatory airway disease, such as asthma and chronic obstructive pulmonary disease (COPD), is a major health burden worldwide. These diseases cause large numbers of deaths each year due to airway obstruction, which is exacerbated by respiratory viral infection. The inflammatory response in the airway is mediated in part through the MAPK pathways: p38, JNK and ERK. These pathways also have roles in interferon production, viral replication, mucus production, and T cell responses, all of which are important processes in inflammatory airway disease. Dual-specificity phosphatases (DUSPs) are known to regulate the MAPKs, and roles for this family of proteins in the pathogenesis of airway disease are emerging. This review summarizes the function of DUSPs in regulation of cytokine expression, mucin production, and viral replication in the airway. The central role of DUSPs in T cell responses, including T cell activation, differentiation, and proliferation, will also be highlighted. In addition, the importance of this protein family in the lung, and the necessity of further investigation into their roles in airway disease, will be discussed.

    Search related documents:
    Co phrase search for related documents
    • aberrant expression and adaptive immunity: 1
    • aberrant expression and low expression: 1, 2, 3, 4, 5, 6, 7, 8
    • aberrant expression and lung damage: 1
    • aberrant expression and lung inflammation: 1
    • aberrant expression and lung injury: 1, 2, 3, 4
    • aberrant expression and lung tissue: 1, 2, 3